Literature DB >> 33940009

The functional role of decorin in corneal neovascularization in vivo.

Praveen K Balne1, Suneel Gupta1, Jinjin Zhang1, Daniel Bristow2, Matthew Faubion2, Sally D Heil1, Prashant R Sinha1, Sydney L Green1, Renato V Iozzo3, Rajiv R Mohan4.   

Abstract

Our earlier decorin (Dcn) gene overexpression studies found that the targeted Dcn gene transfer into the cornea inhibited corneal angiogenesis in vivo using a rabbit model. In this study, we tested the hypothesis that anti-angiogenic effects of decorin in the cornea are mediated by alterations in a normal physiologic balance of pro- and anti-angiogenic factors using decorin deficient (Dcn-/-) and wild type (Dcn+/+) mice. Corneal neovascularization (CNV) in Dcn-/- and Dcn+/+ mice was produced with a standard chemical injury technique. The clinical progression of CNV in mice was monitored with stereo- and slit-lamp microscopes, and histopathological hematoxylin and eosin (H&E) staining. Protein and mRNA expression of pro- and anti-angiogenic factors in the cornea were evaluated using immunofluorescence and quantitative real-time PCR, respectively. Slit-lamp clinical eye examinations revealed significantly more CNV in Dcn-/- mice than the Dcn+/+ mice post-injury (p < 0.05) and AAV5-Dcn gene therapy significantly reduced CNV in Dcn-/- mice compered to no AAV5-Dcn gene therapy controls (p < 0.001). H&E-stained corneal sections exhibited morphology with several neovessels in injured corneas of the Dcn-/- mice than the Dcn+/+ mice. Immunofluorescence of corneal sections displayed significantly higher expression of α-smooth muscle actin (α-SMA) and endoglin proteins in Dcn-/- mice than Dcn+/+ mice (p < 0.05). Quantitative real-time PCR found significantly increased mRNA levels of pro-angiogenic factors endoglin (2.53-fold; p < 0.05), Vegf (2.47-fold; p < 0.05), and Pecam (2.14-fold; p < 0.05) and anti-angiogenic factor Vegfr2 (1.56-fold; p < 0.05) in the normal cornea of the Dcn-/- mice than the Dcn+/+ mice. Furthermore, neovascularized Dcn-/- mice corneas showed greater increase in mRNA expression of pro-angiogenic factors endoglin (4.58-fold; p < 0.0001), Vegf (4.16-fold; p < 0.0001), and Pdgf (2.15-fold; p < 0.0001) and reduced expression of anti-angiogenic factors Ang2 (0.12-fold; p < 0.05), Timp1 (0.22-fold; p < 0.05), and Vegfr2 (0.67-fold; p > 0.05) compared to neovascularized Dcn+/+ mice corneas. These gene deficience studies carried with transgenic Dcn-/- mice revealed decorin's role in influencing a physiologic balance between pro-and anti-angiogenic factors in the normal and injured cornea. We infer that the functional deletion of Dcn promotes irregular corneal repair and aggravates CNV.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Anti-angiogenic factors; Cornea; Corneal neovascularization; Decorin; Gene therapy; Pro-angiogenic factors

Mesh:

Substances:

Year:  2021        PMID: 33940009      PMCID: PMC9250794          DOI: 10.1016/j.exer.2021.108610

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.770


  41 in total

Review 1.  Vascular endothelial growth factor inhibitors for treatment of corneal neovascularization: a meta-analysis.

Authors:  Miltiadis Papathanassiou; Sofia Theodoropoulou; Antonis Analitis; Anastasia Tzonou; Panagiotis G Theodossiadis
Journal:  Cornea       Date:  2013-04       Impact factor: 2.651

2.  Evaluation of corneal neovascularisation.

Authors:  Lana A Faraj; Dalia G Said; Harminder S Dua
Journal:  Br J Ophthalmol       Date:  2011-10       Impact factor: 4.638

3.  Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive.

Authors:  Yuji Oshima; Sachiko Oshima; Hiroyuki Nambu; Shu Kachi; Kyoichi Takahashi; Naoyasu Umeda; JiKui Shen; Aling Dong; Rajendra S Apte; Elia Duh; Sean F Hackett; Godwin Okoye; Kazuki Ishibashi; James Handa; Michele Melia; Stanley Wiegand; George Yancopoulos; Donald J Zack; Peter A Campochiaro
Journal:  FASEB J       Date:  2005-03-31       Impact factor: 5.191

4.  Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy.

Authors:  Rajiv R Mohan; Ashish Tandon; Ajay Sharma; John W Cowden; Jonathan C K Tovey
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

5.  Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis.

Authors:  Bjorn Bachmann; Rod S Taylor; Claus Cursiefen
Journal:  Ophthalmology       Date:  2010-06-03       Impact factor: 12.079

6.  Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.

Authors:  K G Danielson; H Baribault; D F Holmes; H Graham; K E Kadler; R V Iozzo
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

Review 7.  Complex role of matrix metalloproteinases in angiogenesis.

Authors:  Q X Sang
Journal:  Cell Res       Date:  1998-09       Impact factor: 25.617

8.  Angiogenesis in platelet endothelial cell adhesion molecule-1-null mice.

Authors:  Gaoyuan Cao; Melane L Fehrenbach; James T Williams; Jeffrey M Finklestein; Jing-Xu Zhu; Horace M Delisser
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

Review 9.  Limbal stem cell deficiency and corneal neovascularization.

Authors:  Pauline Lim; Thomas A Fuchsluger; Ula V Jurkunas
Journal:  Semin Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.975

10.  Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Gregory S Schultz; John W Cowden; Ashish Tandon
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

View more
  4 in total

1.  Decorin regulates collagen fibrillogenesis during corneal wound healing in mouse in vivo.

Authors:  Suneel Gupta; Filiz Buyank; Nihant R Sinha; DeAna G Grant; Prashant R Sinha; Renato V Iozzo; Shyam S Chaurasia; Rajiv R Mohan
Journal:  Exp Eye Res       Date:  2022-01-11       Impact factor: 3.467

Review 2.  Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways.

Authors:  Christopher Xie; Dipon K Mondal; Mikdat Ulas; Thomas Neill; Renato V Iozzo
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-16       Impact factor: 4.249

Review 3.  Autophagy in Extracellular Matrix and Wound Healing Modulation in the Cornea.

Authors:  Duraisamy Kempuraj; Rajiv R Mohan
Journal:  Biomedicines       Date:  2022-02-01

4.  Decorin Concentrations in Aqueous Humor of Patients with Diabetic Retinopathy.

Authors:  Shermaine W Y Low; Tanuja Vaidya; Santosh G K Gadde; Thirumalesh B Mochi; Devesh Kumar; Iris S Kassem; Deborah M Costakos; Baseer Ahmad; Swaminathan Sethu; Arkasubhra Ghosh; Shyam S Chaurasia
Journal:  Life (Basel)       Date:  2021-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.